Stay updated on Viagenpumatucel-L Combo Therapy in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Viagenpumatucel-L Combo Therapy in NSCLC Clinical Trial page.

Latest updates to the Viagenpumatucel-L Combo Therapy in NSCLC Clinical Trial page
- Check3 days agoChange DetectedA centralized Locations section now lists all study sites by state (Arizona, California, Florida, Indiana, Kentucky, Missouri, New York, Ohio, Oregon, Pennsylvania, Rhode Island, Virginia), replacing the previous per-state location headers. The page also shows an updated Revision: v3.3.3.SummaryDifference1%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check25 days agoChange DetectedThe page shows a minor revision update from Revision: v3.3.1 to v3.3.2; no study content, eligibility criteria, or results are affected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check32 days agoChange DetectedThe page update represents a minor site version change (v3.3.1 added and v3.2.0 removed) with no visible impact on the study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check39 days agoChange DetectedThe site-wide government funding/operating status banner has been removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check53 days agoChange DetectedResults reporting information was added to the page, including the Results First Submitted date, QC criteria status, and the Results First Posted date. This makes the study results visible on the record.SummaryDifference0.3%

- Check82 days agoChange Detected- Added a government funding lapse notice and current operating status guidance for NIH Clinical Center, and a version bump to v3.2.0. - Removed the previous version tag v3.1.0.SummaryDifference3%

Stay in the know with updates to Viagenpumatucel-L Combo Therapy in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Viagenpumatucel-L Combo Therapy in NSCLC Clinical Trial page.